(IPX) IperionX American - NASDAQ
Sector: Basic Materials | Industry: Other Industrial Metals & Mining | Exchange: NASDAQ (USA) | Market Cap: 940m USD | Total Return: -13.1% in 12m
Avg Turnover: 9.12M
Warnings
Interest Coverage Ratio -376.8 is critical
Altman Z'' -1.88 < 1.0 - financial distress zone
Choppy Below Avwap Earnings
Tailwinds
No distinct edge detected
IperionX Limited (NASDAQ: IPX) is a U.S.-based critical minerals company headquartered in Charlotte, North Carolina, and listed on NASDAQ via American Depositary Shares. The company holds a 100% interest in the Titan project in Tennessee, which contains titanium, zircon, and rare earth mineral resources. In addition to mineral development, IperionX produces angular and spherical titanium metal powders, supplying end markets including automotive and transport, consumer electronics, aerospace and defense, energy, medical, luxury goods, and industrial sectors. The company was incorporated in 2017 and rebranded from Hyperion Metals Limited to IperionX Limited in February 2022. Within the Materials sector, the company operates in the Diversified Metals & Mining sub-industry, and its focus on titanium powder production positions it within the additive manufacturing (3D printing) supply chain, where titanium alloys are valued for their high strength-to-weight ratio and corrosion resistance.
- U.S. critical minerals mandates boost domestic titanium demand
- Titan Project production scales toward commercial titanium output
- Capital raises risk persistent dilution amid pre-revenue cash burn
| Net Income: error (cannot be calculated; needs Net Income TTM and Revenue TTM) |
| FCF/TA: -0.87 > 0.02 and ΔFCF/TA -75.35 > 1.0 |
| NWC/Revenue: error (cannot be calculated; needs Current Assets/Liabilities and Revenue current+prev) |
| CFO/TA -0.17 > 3% & CFO -21.8m > Net Income -105.5m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 4.03 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.36m) vs 12m ago -87.57% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 0.0% > 50% (prev 0.0%; Δ 0.0% > 0%) |
| Interest Coverage Ratio: -376.8 > 6 (EBIT TTM -115.2m / Interest Expense TTM 306k) |
| A: 0.40 (Total Current Assets 69.6m - Total Current Liabilities 17.3m) / Total Assets 129.2m |
| B: -1.11 (Retained Earnings -144.0m / Total Assets 129.2m) |
| C: -0.94 (EBIT TTM -115.2m / Avg Total Assets 122.5m) |
| D: 5.16 (Book Value of Equity 108.2m / Total Liabilities 21.0m) |
| Altman-Z'' = -1.88 = D |
As of June 27, 2026, the stock is trading at USD 26.50 with a total of 460,336 shares traded. Over the past week, the price has changed by -14.60%, over one month by -31.96%, over three months by +20.56% and over the past year by -13.11%.
Current recommended Stop Loss: 23.30 (which is 12.1% or 1.3 ATR below the current price).
IperionX American has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy IPX.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 58 | 118.9% |
P/E Forward = 1666.6667
P/B = 9.002
Revenue TTM = 0.0 USD
EBIT TTM = -115.2m USD
EBITDA TTM = -110.3m USD
Long Term Debt = 9.39k USD (from longTermDebt, last quarter)
Short Term Debt = 1.11m USD (from shortTermDebt, last quarter)
Debt = 8.19m USD (from shortLongTermDebtTotal, last quarter) + Leases 3.73m
Net Debt = -57.6m USD (calculated: Debt 8.19m - CCE 65.8m)
Enterprise Value = 882.5m USD (940.1m + Debt 8.19m - CCE 65.8m)
Interest Coverage Ratio = -376.8 (Ebit TTM -115.2m / Interest Expense TTM 306k)
EV/FCF = -7.87x (Enterprise Value 882.5m / FCF TTM -112.1m)
FCF Yield = -12.70% (FCF TTM -112.1m / Enterprise Value 882.5m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 2.27m) / Revenue TTM)
Tobins Q-Ratio = 6.83 (Enterprise Value 882.5m / Total Assets 129.2m)
Interest Expense / Debt = 3.73% (Interest Expense 306k / Debt 8.19m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -91.0m (EBIT -115.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 4.03 (Total Current Assets 69.6m / Total Current Liabilities 17.3m)
Debt / Equity = 0.08 (Debt 8.19m / totalStockholderEquity, last quarter 108.2m)
Debt / EBITDA = 0.52 (negative EBITDA) (Net Debt -57.6m / EBITDA -110.3m)
Debt / FCF = 0.51 (negative FCF - burning cash) (Net Debt -57.6m / FCF TTM -112.1m)
Total Stockholder Equity = 96.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -86.13% (Net Income -105.5m / Total Assets 129.2m)
RoE = -109.5% (Net Income TTM -105.5m / Total Stockholder Equity 96.4m)
RoCE = -119.5% (out of range, set to none) (EBIT -115.2m / Capital Employed (Equity 96.4m + L.T.Debt 9.39k))
RoIC = -80.53% (negative operating profit) (NOPAT -91.0m / Invested Capital 113.0m)
WACC = 12.76% (E(940.1m)/V(948.3m) * Re(12.85%) + D(8.19m)/V(948.3m) * Rd(3.73%) * (1-Tc(0.21)))
Discount Rate = 12.85% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 32.20 | Cagr: -55.68%
[DCF] Fair Price = unknown (Cash Flow -112.1m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.83 | # QB: 0
Revenue Correlation: N/A | Revenue CAGR: N/A | SUE: N/A | # QB: 0
EPS next Quarter (2026-09-30): EPS=-0.33 | Chg30d=+0.00% | Revisions=N/A | Analysts=1
EPS current Year (2026-06-30): EPS=-1.86 | Chg30d=-88.83% | Revisions=N/A | GrowthEPS=-1450.0% | GrowthRev=+0.0%
EPS next Year (2027-06-30): EPS=-0.70 | Chg30d=-42.08% | Revisions=+20% | GrowthEPS=+62.2% | GrowthRev=+1963.1%
[Analyst] Revisions Ratio: +20%